This is this is a private company. But you know, you'll you'll see them in the next probably 3 or 4 years debut as a public business, um, called Pivot BioView on YouTube
Chamath said that Pivot Bio, a private company in May 2021, would “debut as a public business” in about 3–4 years. That window (roughly mid‑2024 to mid‑2025) has passed.
As of 2025, Pivot Bio explicitly describes itself as a private company funded through private investment, with its latest round a 2021 Series D; there is no indication of an IPO, SPAC merger, or direct listing having occurred. (pivotbio.com) Independent coverage in 2025 likewise classifies Pivot Bio among private biotech startups and notes that the underlying analysis was limited to private companies, confirming it has not gone public. (pivotbio.com) Recent 2024–2025 press releases (e.g., on partnerships, relocation, and investor days) present Pivot Bio as an agtech company or startup and make no reference to any stock ticker, exchange listing, or completed public offering. (prnewswire.com)
Given that the 3–4 year timeframe from the May 13, 2021 episode has elapsed and Pivot Bio remains privately held, the prediction that it would be public by then is wrong.